Stability expertise that helps medicines go further
Extended stability helps medicines stay usable for longer, giving healthcare providers greater flexibility in how products are prepared, stored and delivered.
Pharmaxo Compounding's best-in-class extended stability windows can help reduce waste, improve treatment planning and create more opportunities to deliver care across a wider range of healthcare settings.
This capability is underpinned by significant investment in stability science. As part of a global network of stability expertise, with dedicated in-house stability laboratories in both the northern and southern hemispheres, we continue to advance our understanding of how complex medicines perform over time.
Our award-winning R&D team has developed extended stability data for many complex therapies, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs) and cytotoxic medicines. Working closely with the NHS Pharmaceutical Research and Development Working Group, our research has helped inform updates to NHS guidance on medicine stability.
Greater stability, greater flexibility
Unique, proven stability profiles help healthcare providers better coordinate medicine preparation, storage and delivery across complex treatment pathways. Our advanced stability expertise has significantly extended the usable life of several complex medicines, creating greater flexibility between preparation and administration while helping treatment pathways run more smoothly.
Unlocking access to treatment
Historically, short shelf-lives have limited how and where some complex medicines can be used. Our extended stability profiles can help make these medicines available across a wider range of healthcare environments including satellite clinics, mobile treatment centres and homecare settings.
Reducing waste and improving efficiency
By helping medicines stay usable for longer, extended stability can help reduce waste, improve inventory management and support safe large-scale batch preparation while maintaining product quality and integrity.
Enabling care beyond the hospital
Extended stability helps healthcare providers better coordinate treatment across hospitals, clinics and homecare settings. Longer stability windows can support more flexible treatment delivery models, helping more patients access care closer to home while reducing pressure on hospital services.
Scientific expertise, integrated
Our stability expertise is built into every stage of the manufacturing process, from preparation and storage through to delivery. Supported by specialist scientific teams, two dedicated stability laboratories and carefully controlled manufacturing environments, Pharmaxo Compounding continues to develop stability data that helps unlock new treatment possibilities while maintaining product quality.
-
132
stability studies completed
-
81
medication shelf-life extensions
-
2
stability labs globally
Ready-to-administer, made to last
Stability-supported manufacturing pathways
Ready-to-administer medicine preparation
CIVAS and aseptic preparation services
Stability-led inventory and supply support
Large-scale batch manufacturing
